Together, these data show that chronic inhibition of Akt1 and Akt2 kinase can be achieved in mice, at levels sufficient to recapitulate the Akt-dependence of breast cancer cells with HER2 amplification or PIK3CA mutation seen in vitro. The gene discussed is AKT1; the disease is breast cancer.